pharma · MASH · MASLD · SGMT
Sagimet Biosciences
Sagimet Biosciences trial registry — 12 ClinicalTrials.gov studies with program phase, status, and indication context.
155 Bovet Rd, Suite 303, San Mateo, California 94402, US HQ
27 Employees
Public company Type
SGMT · NYSE Ticker
Company details
- Status
- Public
- HQ
- 155 Bovet Rd, Suite 303, San Mateo, California 94402, US
- Employees
- 27
- Programs
- 12
- Drugs
- 4
- Patents
- 1
Sagimet Biosciences clinical trials
Registry index of 12 ClinicalTrials.gov studies linked to Sagimet Biosciences programs — each row shows trial ID, program name, phase, status, and indication.
Sagimet Biosciences trial registry — 12 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Sagimet Biosciences.
-
TVB-2640 25 mg (US) — Phase 2
Clinical update -
3-V Bioscience-2640 — Phase 2
Clinical update -
TVB-2640 — Phase 1
Clinical update -
TVB-2640 — Phase 2
Clinical update -
TVB-2640 - 50 mg — Phase 1
Clinical update -
Denifanstat — Phase 3
Clinical update -
denifanstat — Phase 3
Clinical update -
TVB-2640 — Phase 2
Clinical update
Trial registry
-
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ - NCT03938246CT.gov ↗
TVB-2640 25 mg (US)
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
- NCT04906421CT.gov ↗
TVB-2640
Metabolic Dysfunction-assocated Steatohepatitis/ Nonalcoholic Fatty Liver Disease
-
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗